Brief: Kuros Biosciences receives clearance from FDA for MagnetOs

Kuros Biosciences AG

27/02/2017 06:00

Feb 27 (Reuters) - Kuros Biosciences AG  KURN.S : 
    * Receives clearance from FDA for magnetos allowing 
marketing in United States 
    * FDA's approval clearance allows marketing in United States 
indicated for use as an autograft extender in posterolateral 
spine 
 
Source text for Eikon:  ID:nTEN4d8haa  
Further company coverage:  KURN.S  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 722 0920;))